Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Left ventricular diastolic dysfunction and diastolic heart failure.

William H Gaasch1, Michael R Zile

  • 1Department of Cardiovascular Medicine, Lahey Clinic, Burlington, Massachusetts 01805, USA. William.H.Gaasch@Lahey.org

Annual Review of Medicine
|January 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Tirzepatide in Obesity-Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial.

JACC. Heart failure·2026
Same author

Changes in Pulmonary Artery Pressure Following Initiation of Guideline-Directed Medical Therapies in Patients With Heart Failure: Insights From GUIDE-HF.

Circulation. Heart failure·2026
Same author

Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial.

Journal of the American College of Cardiology·2026
Same author

Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial.

Journal of the American College of Cardiology·2026
Same author

Baroreflex Activation Therapy In Heart Failure-the Barostim-Enabled Neurohormonal Intervention for Improving Treatment of Heart Failure (BENEFIT-HF) Trial Rationale and Design.

Journal of cardiac failure·2026
Same author

Kidney Failure Risk Equation and Risk of Kidney and Cardiovascular Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Insights from PARADIGM-HF.

European journal of heart failure·2026

Diastolic heart failure, characterized by normal left ventricular ejection fraction, affects 30-50% of heart failure patients. Echocardiography distinguishes it from systolic heart failure, guiding management to reduce congestion and underlying causes.

Area of Science:

  • Cardiology
  • Medical Diagnostics

Background:

  • Heart failure presents with signs and symptoms in 30-50% of patients with normal left ventricular (LV) systolic ejection fraction.
  • Clinical examination alone cannot differentiate between diastolic heart failure and systolic heart failure.

Purpose of the Study:

  • To highlight the diagnostic role of echocardiography in identifying diastolic heart failure.
  • To outline the primary management objectives for patients with diastolic heart failure.

Main Methods:

  • Echocardiography is identified as the key diagnostic tool.
  • Management strategies focus on two main objectives.

Main Results:

  • Echocardiography can accurately distinguish diastolic heart failure from systolic heart failure.

Related Experiment Videos

  • Management aims to resolve venous congestion and address underlying causes of diastolic dysfunction.

    • Conclusions:

    • Diastolic heart failure is a significant clinical entity often indistinguishable from systolic heart failure by physical exam alone.
    • Effective management requires accurate diagnosis via echocardiography and a dual approach targeting both symptoms and underlying pathology.